[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-334497-105":59,"doc-detail-334497-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","rna-binding-proteins-in-cancer-chemotherapeutic-drug-resistance","RNA binding proteins in cancer chemotherapeutic drug resistance","","RNA binding proteins (RBPs) influence cancer progression and contribute to chemotherapeutic drug resistance by regulating post-transcriptional gene modifications and multiple tolerance-related pathways. Many chemotherapies fail to overcome chemoresistance, and the mechanisms driving resistance are incompletely understood across cancers. This review outlines RBP-mediated mechanisms of resistance, including roles of major RBPs and their connections with noncoding RNAs linked to reduced chemosensitivity, and highlights implications for improved diagnosis and treatment strategies.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/rna-binding-proteins-in-cancer-chemotherapeutic-drug-resistance/334497/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/rna-binding-proteins-in-cancer-chemotherapeutic-drug-resistance/334497.png","ImageObject",300,407,{"name":92,"@type":93},"Himbo","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":19},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why is chemotherapeutic drug resistance a major obstacle in cancer treatment?","Question",{"text":112,"@type":113},"Drug resistance prevents many chemotherapies from achieving durable tumor remission. Tumor cells can develop intrinsic and acquired resistance, and multiple resistance mechanisms can act together during invasion and metastasis.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What roles do RNA binding proteins (RBPs) play in chemoresistance?",{"text":117,"@type":113},"RBPs regulate post-transcriptional gene expression and affect pathways tied to drug tolerance. Their abnormal expression is associated with cancer progression and multiple processes implicated in resistance.",{"name":119,"@type":110,"acceptedAnswer":120},"How does the review connect RBPs with noncoding RNAs and chemosensitivity?",{"text":121,"@type":113},"The review describes correlations between major RBPs and noncoding RNAs (ncRNAs), including miRNAs, that are associated with inhibiting chemosensitivity. Exploring RBP-mediated pathways is presented as relevant for developing improved therapeutic strategies.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},334497,1790192952,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":19,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":4},687197100911,"https://ap-avatar.wpscdn.com/avatar/a000239b6f1da00475?x-image-process=image/resize,m_fixed,w_180,h_180&k=1785132997149421697","TYPE Review  \nPUBLISHED 24 January 2024 DOI 10.3389/fcell.2024.1308102  \nOPEN ACCESS  \nEDITED BY  \nTianxiang Hu,  \nAugusta University, United States  \nREVIEWED BY  \nBruno Pereira,  \nUniversidade do Porto, Portugal Preet Lal,  \nWashington University in St. Louis, United States  \n*CORRESPONDENCE  \nJohnson Rajasingh,  [rjohn186@uthsc.edu](rjohn186@uthsc.edu)[ ](rjohn186@uthsc.edu)Satish Ramalingam,  [rsatish76@gmail.com](rsatish76@gmail.com)  \nRECEIVED 05 October 2023  \nACCEPTED 12 January 2024  \nPUBLISHED 24 January 2024  \nCITATION  \nVembuli H, Gor R, Ramalingam S, Perales S and Rajasingh J (2024), RNA binding proteins in cancer chemotherapeutic drug resistance. Front. Cell Dev. Biol. 12:1308102 .  \ndoi: 10.3389/fcell.2024.1308102  \nCOPYRIGHT  \n© 2024 Vembuli, Gor, Ramalingam, Perales and Rajasingh. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nRNA binding proteins in cancer chemotherapeutic drug resistance  \nHemanathan Vembuli 1,2, Ravi Gor 1, Satish Ramalingam 1*, Selene Perales 2 and Johnson Rajasingh 1,2,3*  \n1Department of Genetic Engineering, School of Bio-Engineering, SRM Institute of Science and Technology, Kattankulathur, Tamil Nadu, India, 2Department of Bioscience Research, University of Tennessee Health Science Center, Memphis, TN, United States, 3Department of Microbiology, Immunology, and Biochemistry, University of Tennessee Health Science Center, Memphis, TN, United States  \nDrug resistance has been a major obstacle in the quest for a cancer cure. Many chemotherapeutic treatments fail to overcome chemoresistance, resulting in tumor remission. The exact process that leads to drug resistance in many cancers has not been fully explored or understood. However, the discovery of RNA binding proteins (RBPs) has provided insight into various pathways and posttranscriptional gene modiﬁcations involved in drug tolerance. RBPs are evolutionarily conserved proteins, and their abnormal gene expression has been associated with cancer progression. Additionally, RBPs are aberrantly expressed in numerous neoplasms. RBPs have also been implicated in maintaining cancer stemness, epithelial-to-mesenchymal transition, and other processes. In this review, we aim to provide an overview of RBP-mediated mechanisms of drug resistance and their implications in cancer malignancy. We discuss in detail the role of major RBPs and their correlation with noncoding RNAs (ncRNAs) that are associated with the inhibition of chemosensitivity. Understanding and exploring the pathways of RBP-mediated chemoresistance will contribute to the development of improved cancer diagnosis and treatment strategies.  \nKEYWORDS  \nRNA binding proteins, cancer, drug resistance, cancer stem cells, miRNA, and lncRNA  \nIntroduction  \nCancer remains one of the leading causes of mortality worldwide. Despite advances in chemotherapeutic strategies, drug resistance continues to hinder progress towards a cure. Reports indicate that 90% of drug resistance occurs during tumor invasion and metastasis (Dreyfuss et al., 2002; Mansoori et al., 2017) . While much research has focused on intrinsic resistance (pre-existent) and acquired resistance (induced by drugs), tumors can inherit a combination of these resistance mechanisms (Vasan et al., 2019) . The independent and combined effects of mechanisms such as drug inactivation, drug target alteration, drug efﬂux (ABC transporters), DNA damage repair, inhibition of cell death, epithelial tomesenchymal transition (EMT), cancer cell heterogeneity, and epigenetic modiﬁcation (DNA methylation, histone modiﬁcation, etc.) signiﬁcantly reduce","cbCair3VxBfKm1Ix","https://ap.wps.com/l/cbCair3VxBfKm1Ix","pdf",2632502,17,"English","# Introduction\n## Mechanisms of cancer drug resistance and therapy challenges\n## RBP-mediated chemoresistance overview\n# RNA binding proteins (RBPs)\n## RBPs and post-transcriptional regulation","[{\"question\":\"Why is chemotherapeutic drug resistance a major obstacle in cancer treatment?\",\"answer\":\"Drug resistance prevents many chemotherapies from achieving durable tumor remission. Tumor cells can develop intrinsic and acquired resistance, and multiple resistance mechanisms can act together during invasion and metastasis.\"},{\"question\":\"What roles do RNA binding proteins (RBPs) play in chemoresistance?\",\"answer\":\"RBPs regulate post-transcriptional gene expression and affect pathways tied to drug tolerance. Their abnormal expression is associated with cancer progression and multiple processes implicated in resistance.\"},{\"question\":\"How does the review connect RBPs with noncoding RNAs and chemosensitivity?\",\"answer\":\"The review describes correlations between major RBPs and noncoding RNAs (ncRNAs), including miRNAs, that are associated with inhibiting chemosensitivity. Exploring RBP-mediated pathways is presented as relevant for developing improved therapeutic strategies.\"}]","RNA binding proteins in cancer chemotherapeutic drug resistance | PDF",1790006892,43]